View all news

    The European Commission Approves Expanded Use Of JANSSEN’S STELARA® (USTEKINUMAB) For The Treatment Of Paediatric Patients With Moderate To Severe Plaque Psoriasis

    01/23/2020
    Download(opens in new window)PDF 178 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com